Akorn receives FDA OK for generic CetrotideGeneric Cetrotide is used to prevent premature ovulation during controlled ovarian stimulation. Upsher-Smith, Emphascience ink deal for specialty branded generic productEmphascience will develop the product exclusively for Upsher-Smith, which will manufacture, market and distribute it under its own label in the United States. Glenmark obtains FDA OK for generic Taytulla Generic Taytulla is used for the prevention of pregnancy. Strides receives FDA nod for generic Neoral Generic Neoral is used as an immunosuppressant medication. Israel Makov to retire as chairman of Sun Pharma After having led for 10 years, Makov is retiring as Sun Pharma's chairman and member of the board. Mayne Pharma, Mithra Pharmaceuticals obtain FDA permission for generic Nuvaring Mayne Pharma anticipates the commercial launch of Haloette ring by early 2023. Mayne Pharma sells Metrics Contract Services to Catalent for $475M Metrics Contract Services provides a broad range of services, from drug development to commercial manufacturing, from its facility in Greenville, N.C. Amneal appoints Deborah Autor to board of directors Autor has biopharmaceutical industry expertise in quality, regulatory and policy. FDA approves Bioeq’s Lucentis biosimilar Cimerli is the only biosimilar approved for all five Lucentis indications. ANI acquires 4 ANDAs from Oakrum Pharma With the acquisition, ANI said it expects to launch four generic products in 2023. First Previous 87 88 89 90 91 Next Last
